Top

Publications list

Area

Group

Year

Disease

Text

Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report

Activity survey office

1st listed author

Bone Marrow Transplant.

Accuracy and usability of the eGVHD app in assessing the severity of graft-versus-host disease at the 2017 EBMT annual congress.

Transplant Complications Working Party (TCWP)

1st listed author

Bone Marrow Transplant.

Handling, processing and disposal of stem cell products in Europe: A survey by the cellular therapy and immunobiology working party of the European Society for Blood and Marrow Transplantation.

Cellular Therapy & Immunobiology Working Party (CTIWP)

JACIE Committee

1st listed author

Autologous hematopoietic stem cell transplantation (AHSCT) in severe Crohn‘s Disease: a review on behalf of ECCO and EBMT.

Autoimmune Diseases Working Party (ADWP)

JACIE Committee

1st listed author

J Crohn‘s Colitis.

Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents.

Chronic Malignancies Working Party (CMWP)

1st listed author

Biol Blood Marrow Transplant.

Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party.

Lymphoma Working Party (LWP)

1st listed author

Bone Marrow Transplant.

Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party.

Chronic Malignancies Working Party (CMWP)

1st listed author

Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the European Group for Blood and Marrow Transplant Chronic Malignancies Working Party.

Chronic Malignancies Working Party (CMWP)

1st listed author

Haploidentical transplant in patients with myelodysplastic syndrome.

Chronic Malignancies Working Party (CMWP)

1st listed author

Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases.

Autoimmune Diseases Working Party (ADWP)

Paediatric Diseases Working Party (PDWP)

JACIE Committee

1st listed author

Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation.

Chronic Malignancies Working Party (CMWP)

1st listed author

Response Assessment in Myeloma: Practical Manual on Consistent Reporting in an Era of Dramatic Therapeutic Advances.

Chronic Malignancies Working Party (CMWP)

1st listed author

Biol Blood Marrow Transplant.

Need help?

First Name

Last Name

Email address

CIC number

Area of interest

Message box

I understand and accept that my personal data will be used for communication concerning the submitted query or request.

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to data.protection@ebmt.org